Saundra Pelletier is the CEO of Evofem Biosciences, Inc., a biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women’s sexual and reproductive health. The company is developing EVO100, which is currently in a Phase 3 clinical trial for prevention of chlamydia and gonorrhea.
In September 2020, Evofem launched Phexxi - the first and only, non-hormonal, on-demand, prescription birth control for women.
Start the Convo to raise awareness and end sexual assault. #StartTheConvo campaign is a call to action for every member of our community to give their support and #StartTheConvo around preventing intimate partner violence and sexual violence. We stand in solidarity with all survivors of intimate partner violence and sexual assault. We all have a role in ending violence.
The highest incidence of rape affects mostly yong women between the ages of 16 and 24. Don’t be a bystander! It’s time to talk with your friends, family, and loved ones! Join us as we #StartTheConvo!